INNV Stock Cash Flow Statements

InnovAge Holding Corp Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

InnovAge Holding Corp Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2019-09-30	2019-06-30	2019-03-31	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31

cash flows from operating activities:
net income	-2,236,000	-1,759,000	-1,989,000	-1,840,228	-1,828,892	-1,495,594	-1,328,657	-1,134,050	-2,545,787	-3,360,033	-4,425,812	-4,360,340	-1,554,969	-1,175,291	-1,126,647	-1,085,615	-1,439,414
adjustments to reconcile net income to net cash from operating activities:
depreciation	17,000	18,000	17,000		6,991	3,493	2,838	2,598	2,822	-3,899	2,061	3,684	3,686	47,842	-13,750	8,155	21,203
recovery of allowance for doubtful accounts	-1,000	-4,000	-7,000
common stock, restricted stock units and stock options issued to employees, board of directors and consultants for compensation and services	139,000	137,000	138,000	109,771	115,459	138,581	254,729	161,907	580,394
loss on extinguishment of debt	0			38,587	255,685	305,891	89,341	0	304,828
change in fair value of contingent consideration	0	-4,000	-2,000	-21,645	2,845	1,425	-69,305	-98,979	-27,175
amortization of debt discount	480,000	447,000	461,000	304,688	229,404	90,456	86,250	88,474	512,874	649,100			370,760
amortization of intangible assets	179,000	178,000	185,000	157,473	157,475	157,473	157,477	157,473	157,725	110,637	178,082	178,083	157,602
changes in operating assets and liabilities, net of acquisition amounts
accounts receivable	204,000	-185,000	158,000	-92,108	-126,804	-42,710	-7,192	-7,771	15,922	-3,848	-3,938	23,034	32,208	236,719	-275,186	57,735	5,772
prepaid expense and other current assets	173,000	-138,000	-458,000	-360,794	29,944	-64,781	88,845	-12,623	101,075
inventories	110,000	278,000	552,000	-580,453	76,968	-1,085,643	-53,600	-49,815	63,216	-203,084	-174,335	49,993	-17,987
operating lease right-of-use asset and liability	-7,000	-7,000	-7,000
accounts payable and accrued expense	703,000	271,000	30,000	351,931	121,948	1,251,064	99,506	286,799	119,702
accrued compensation	-405,000	71,000	130,000	-846,664	169,916	-82,894	156,552	90,028	186,918	275,737				115,788	125,808	110,719	158,947
accrued interest payable	43,000	18,000	15,000	15,040	8,023	2,841	7,991	8,298	-22,383	20,931	-45,171	25,470	30,677
deferred revenue and customer deposits	87,000	-200,000	175,000	-44,819	118,079	24,690	-46,769			0	3,246	0	-16,325
net cash from operating activities	-514,000	-754,000	-602,000	-2,797,595	-663,138	-815,196	-577,235	-473,657	-495,635	-1,044,786	-995,624	361,641	-105,489	53,642	-359,787	-286,821	-248,304
capex	-5,000	0	0	13,090	-147,922	-34,505	-2,083	-5,792	-2,256	0	0	0	-6,565	0	0	0	0
free cash flows	-519,000	-754,000	-602,000	-2,784,505	-811,060	-849,701	-579,318	-479,449	-497,891	-1,044,786	-995,624	361,641	-112,054	53,642	-359,787	-286,821	-248,304
cash flows used in investing activities:
purchase of property and equipment	-5,000			13,090	-147,922	-34,505	-2,083	-5,792	-2,256
asset acquisition	0
contingent consideration payment
net cash from investing activities	-5,000	-16,000	-343,000			-47,385				-15,538	-150,000
cash flows from financing activities:
payments on short-term loans payable	-153,000	-434,000	-230,000	-25,578	-32,624	-25,272				0	-71,156	-78,075	-102,920
proceeds from short-terms loans payable	0	678,000	375,000
proceeds from notes payable	1,000,000	1,250,000	400,000	0	1,872,500				150,000
payments on notes payable	-947,000	-1,097,000	-1,615,000	-624,218	-508,630	-212,347	-75,042	-71,270	-67,688	-64,288	-158,256
proceeds from sale of common stock and warrants, net of offering costs	0	0	2,714,000			0	0	0	3,307,773
proceeds from stock option and warrant exercises					2,838,751	0
net cash from financing activities	-100,000	397,000	1,644,000	-524,796	4,169,997	1,082,381	69,744	-71,270	2,043,310	435,712	2,402,036	-196,061	88,706	8,511	322,021	217,125	329,253
net change in cash	-619,000	-373,000	699,000	-3,309,301	3,358,937	249,800	-509,574	-550,719	1,545,419	-624,612	1,256,412	165,580	-23,348	619	-37,766	-69,696	80,949
cash at beginning of period	0	0	1,248,000	0	1,564,859		0	0	829,933		0	0	55,901	-1	0	0	33,374
cash at end of period	-619,000	-373,000	1,947,000	-3,309,301	4,923,796		-509,574	-550,719	2,375,352		1,256,412	165,580	32,553	618	-37,766	-69,696	114,323
supplemental disclosures of cash flow information:
cash paid for interest	0	8,000	21,000	0	2,157	0	9,587	13,625	66,719	23,590	118,371	77,550	9,535
supplemental disclosures of non-cash investing and financing activities:
common stock issued for conversion of convertible debentures, notes payable and accrued interest	0				166,667	515,546
relative fair value of common stock issued in connection with notes payable recorded as debt discount and settlement of contingent consideration
fair value of common stock issued to consultants for services	53,000
offering costs in connection with warrant exercises included in accounts payable and accrued expense					181,213
cumulative adjustment to accumulated deficit for the fair value of the warrant derivative liability upon adoption of asu 2017-11 on january 1, 2018				0	58,609
fair value of common stock issued as financing fees in connection with notes payable recorded as debt discount	0	28,000	28,000	0	122,500
●
relative fair value of common stock issued in connection with notes payable recorded as debt discount		306,000	61,000		292,129	117,519	55,169			182,203	0
purchase of intangible assets			-343,000
cash paid for operating lease liabilities			65,000
allowance for doubtful accounts						1,977	814	1,698	2,578	1,148	-4,790	0	5,708
change in fair value of derivative liabilities						-15,542	-16,055	-3,463	51,656	-697,687	-1,350,688	2,040,909	-57,594
deposits
deferred rent
cash flows from investing activities:
acquisitions, net of cash acquired
payment on contingent consideration
proceeds from short-term loans payable										0	0	11,500	10,300
proceeds from notes payable and convertible debentures						1,350,000	150,000			500,000	2,657,500
issuance of common stock for services
payments on convertible debentures						0	0	0	-1,222,422
prepayment penalty on extinguishment of convertible debentures						0	0	0	-127,247
cash at beginning of year
cash at end of year
cash paid for income taxes						0	0	3,200	2,400
reclassification of the fair value of the embedded conversion features from derivative liability to additional paid-in capital upon conversion						0	0			149,162	944,101
offering costs in connection with warrant exercises included in accounts payable and accrued expenses
fair value of non-forfeitable common stock issued to consultant included in accounts payable and accrued expense						0	0
fair value of common stock issued for prepayment of future royalties due under the cri license agreement included in prepaid expense and other current assets						0	0
proceeds from short-term loans payable for payment of business insurance premiums
depreciation & amortization
(recovery of) allowance for doubtful accounts				0	-179
proceeds from warrant and stock option exercises
common stock issued for conversion of convertible debentures and accrued interest								0	350,610
reclassification of the fair value of the embedded conversion features from derivativeliability to additional paid-in capital upon conversion
relative fair value of common stock issued in connection with notes payablerecorded as debt discount
issuance of shares of common stock for vested restricted stock units						0	0			87	341	1,591	17,297
fair value of non-forfeitable common stock issued to consultant recorded as prepaid expense and other current assets
fair value of embedded conversion feature in convertible debentures in excess of allocated proceeds											1,818,059
repayments of line of credit convertible debenture – related party													-42,500
financing costs in connection with convertible debentures
proceeds from note payable paid to seller in connection with acquisition										0	0	0	300,000
financing costs paid with proceeds from note payable										0
cashless exercise of warrants										0	191
fair value of the contingent consideration for acquisition										15,521	0	0	314,479
reclassification of the fair value of the warrants from derivative liability to additional paid-in capital upon cashless exercise										0	0
relative fair value of warrants issued in connection with convertible debentures recorded as debt discount										0	259,077
relative fair value of common stock issued in connection with convertible debentures recorded as debt discount										0
fair value of embedded conversion feature derivative liabilities recorded as debt discount										0	216,561
fair value of warrants issued to placement agents in connection with convertible debentures recorded as debt discount										0
fair value of unamortized non-forfeitable common stock issued to consultant included in prepaid expense and other current assets
common stock issued to novalere holdings for payment of the acquisition contingent consideration as a result of an amendment and supplement to the registration rights and stock restriction agreement
fair value of beneficial conversion feature on line of credit convertible debenture – related party										0	0	1,611	1,833
relative fair value of common stock issued in connection with convertible debenturesrecorded as debt discount
proceeds from short-term loan payable for payment of d&o insurance premium
proceeds from stock option exercises								0	2,894
relative fair value of common stock subscribed but unissued in connection with convertible debentures recorded as debt discount
deferred financing costs included in accounts payable and accrued expense
net proceeds from convertible debentures in escrow included in restricted cash
changes in operating assets and liabilities, net of acquisition amounts:
supplement disclosures of non-cash investing and financing activities:
reclassification of the fair value of the embedded conversion features from derivative liability to additional paid-in capital upon conversion									203,630
relative fair value of common stock issued in connection with notes payable recorded as debt discount									44,217
fair value of non-forfeitable common stock issued to consultant recorded as prepaid expense and other current assets									15,000
fair value of non-forfeitable common stock issued to consultant included in accounts payable and accrued expense as of december 31, 2016									180,000
fair value of common stock issued for prepayment of future royalties due under the cri license agreement included in prepaid expense and other current assets									44,662
fair value of beneficial conversion feature on line of credit convertible debenture – related party
cash flows from operating activities
gain on purchase price adjustment to goodwill
impairment of goodwill
non-cash gain on settlement of contingent consideration
shares of common stock issued for debt amendment
fair value of embedded conversion feature in convertible debentures in excess of allocated proceeds
cash flows from investing activities
payments on contingent consideration
cash flows from financing activities
financing costs in connection with issuance of convertible debentures
proceeds from warrant exercises										0
proceeds from non-convertible debentures – related party
payments on non-convertible debentures – related party										0
supplemental disclosures of cash flow information :
common stock issued for conversion of notes payable, convertible debentures and accrued interest										328,805	1,420,265
common stock issued for acquisition
fair value of warrant derivative liabilities recorded as debt discount
fair value of non-forfeitable common stock to be issued to consultant included in prepaid expense and other current assets and accounts payable and accrued expense
return of shares of common stock related to license agreement
accrued interest added to principal in connection with amendment of notes payable
adjustments to reconcile net income to net cash from operating activities
common stock, restricted stock units and stock options issued for services and board compensation											665,896	484,295	739,646
stock issued for interest on debt amendment
gain on return of shares of common stock issued in semprae merger
imputed interest on contingent consideration											7,968	16,750	5,584
non-cash gain on contingent consideration
prepaid expenses and other current assets
accounts payable and accrued expenses											549,481	208,156	170,407	95,593			101,897
payments on beyond human contingent consideration
proceeds from (repayments of) line of credit convertible debenture – related party											-290,192
fair value of unamortized non-forfeitable common stock issued to consultant included in prepaid expenses and other current assets
fair value of non-forfeitable common stock to be issued to consultant included in prepaid expenses and other current assets and accounts payable and accrued expenses
common stock issued in connection with debt amendment
amortization of debt discount and deferred financing costs
prepaid expenses												-144	25,108			-24,988	23,155
security deposits
purchase of property & equipment												0	-6,565
deferred financing costs in connection with convertible debentures
supplemental disclosures of non-cash investing & financing activities:
fair value of warrants issued to placement agents recorded as debt discount
deferred financing costs included in accounts payable and accrued expenses
deferred financing costs paid with proceeds from note payable												0	7,500
fair value of unamortized non-forfeitable common stock issued to consultant included in prepaid expenses
cash flows used in investing activities
proceeds from note payable and convertible debentures													242,500
payments on note payable													-18,674
proceeds from non-convertible debentures - related party
common stock issued for conversion of notes payable
gain of purchase price adjustment to goodwill
amortization of deferred financing costs
net proceeds from (repayments of) line of credit convertible debenture – related party
proceeds from convertible debentures
fees paid in connection with issuance of convertible debentures
payments on notes payable and convertible debentures
payment made on contingent consideration
payments on non-convertible debentures - related party
common stock issued for conversion of debentures – related party
common stock issued for extinguishment of debt
common stock issued for the purchase of vesele
fair value of warrants issued as deferred financing costs
relative fair value of common stock issued in connection with convertible debentures
relative fair value of warrants issued in connection with convertible debentures
exchange of restricted stock units for shares of common stock
adjustments to reconcile net income to net cash used by operating activities
stock based compensation
common stock, stock units and stock options issued for services and board compensation
change in fair value of derivative liability
gain on return of shares issued in semprae merger
excess of fair value of debentures over proceeds on new financing
amortization of intangibles														42,697	27,265
inventory														-35,956	-29,199	7,362	-30,315
short-term loans, credit cards and other current liabilities
deferred revenue														-99,996	-25,000	-61	-25,288
purchase of equipment
intangible assets
proceeds from convertible debenture - related party
proceeds from short-term loans
payments on short-term loans
proceeds from notes payable - related party																	25,000
payments on notes payable - related party
supplemental disclosures of cash flow information - fair value of:
common stock issued for conversion of debt
common stock issued and issuable for acquisition
common stock and cash potentially issuable for acquisition
share return – semprae acquisition
return of common stock shares related to license agreement
shares issued in conjunction with debt amendment
warrants issued as deferred financing costs
fair value of warrants and conversion feature issued with convertible debentures
see accompanying notes to these condensed consolidated financial statements.
adjustments to reconcile net income to net cash used by operating activities:
stock compensation																	564,226
common stock, stock units, and stock options issued for services
debt discount
extinguishment of debt
interest payable														17,670	28,593	17,112	22,978
acquisition of semprae inc, cash received
proceeds (repayment) from notes payable														0	40,000	0	300,000
proceeds from convertible debt														0
proceeds from stock issued for cash
proceeds from debentures - related party														0	25,000
proceeds from loc convertible debt - related party
repayment of assumed debt related to acquistion of semprae
repayment of dawson james note
supplemental disclosures of cash flow information
common stock of 1,900,000 shares issued for extinguishment of debt														0
common stock of 1,855,747 shares issued for conversion of convertible debt														11,507	0	0	742,300
common stock of 142,857 shares issued for the purchase of vesele
common stock of 631,313 shares issued with the cri asset purchase agreement
common stock of 83,103 shares issued for conversion of convertible debt
common stock of 3,201,776 shares issued for acquisition of semprae laboratories, inc.
balance at december 31, 2012
common stock issued for services
stock compensation expense
common stock issued for purchase of sensum+ license
common stock sold to related party for cash
common stock issued upon conversion of debt
convertible debt discount
net income for year ended december 31, 2013
balance at december 31, 2013
common stock and options issued for services
common stock issued for product acquisition
common stock issued upon conversion of debt, of which 1,579,297 shares were issued to related parties
convertible debt discount - beneficial conversion feature
convertible debt discount - warrants
net income for year ended december 31, 2014
balance at december 31, 2014
stock-based compensation															282,953
fair value of common stock, stock units, and stock options issued for services
prepaid expenses and deposits
proceeds from convertible debt - related party															207,021	117,125	4,253
accounts payable and accrueds
supplemental disclosures of
cash flow information
adjustments to reconcile net income to
net cash used by operating activities:
common stock and stock units issued for services																	153,754
debt discount write-off in connection with conversion of notes payable																	143,612
accretion of debt discount																	41,832
amortization expense																	9,337
3

We provide you with 20 years of cash flow statements for InnovAge Holding Corp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of InnovAge Holding Corp stock. Explore the full financial landscape of InnovAge Holding Corp stock with our expertly curated income statements.

The information provided in this report about InnovAge Holding Corp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.